Glaxosmithkline Consumer Healthcare Limited - Company Profile

It is a food and beverages public limited company based in Nabha, Punjab, India, established in 1958.

1958 Nabha, Punjab, India Amalgamated

Last Updated: June 24, 2025

About Glaxosmithkline Consumer Healthcare Limited

Glaxosmithkline Consumer Healthcare Limited, a amalgamated public limited company, was established on 30 October 1958 in Nabha, Punjab, India. Engaging in organic & health foods within the food and beverages sector, it holds CIN: L24231PB1958PLC002257. Registered under ROC Roc Chandigarh. it is listed. It has an authorized capital of ₹60.00 Cr and a paid-up capital of ₹42.06 Cr.

It upholds a compliant status. In 2019, it reported revenue of ₹5,214.61 Cr and a net worth of ₹4,094.71 Cr. Employing 1,297 professional, Its leadership includes Pradeep Vasudeo Bhide (Director), Nitin Mathur (Cfo), Sangeeta Talwar (Director). Past directors included Vivek Anand, Pradeep Vasudeo Bhide, Naresh Dayal. It holds no open charges and ₹279.50 Cr settled loans. Its latest AGM occurred on 02 August 2019, with the balance sheet filed on 31 March 2019. It is based at Patiala Road,Nabha, Distt. Patiala, Nabha, Punjab, 147201.

Company Details

CIN/LLPIN
L24231PB1958PLC002257
Registration Number
002257
Incorporation Date
30 October 1958
Authorized Capital
₹60.00 Cr
Paid-Up Capital
₹42.06 Cr
ROC Code
Roc Chandigarh
Listing Status
Listed
Company Status
Amalgamated

Key Metrics

Authorised Capital ₹ 60.00 Cr as on 24-06-2025
Paid Up Capital ₹ 42.06 Cr as on 24-06-2025
Company Age 67 Year, 4 Months
Last Filing with ROC 31 Mar 2019
Satisfied Charges ₹ 279.50 Cr as on 24-06-2025
Revenue Growth **** 12.52% (FY 2019)
Profit Growth **** 40.38% (FY 2019)
Ebitda **** 29.16% (FY 2019)
Net Worth 17.49% (FY 2019)
Total Assets **** 12.11% (FY 2019)

Comprehensive Company Insights

Explore comprehensive insights into Glaxosmithkline Consumer Healthcare Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Glaxosmithkline Consumer Healthcare Limited?

Current Directors

Name	Designation	Appointment Date	Status
Pradeep Vasudeo Bhide	Director	10 May 2019	Current
Nitin Mathur	Cfo	01 Nov 2019	Current
Sangeeta Talwar	Director	06 Aug 2014	Current
Patnam Dwarakanath	Nominee Director	09 Apr 2013	Current
Navneet Saluja	Managing Director	01 Jan 2018	Current
Subramanian Madhavan	Director	25 Sep 2018	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Whole-Time Director	27 Sep 2019	Past
Pramod Abcsdd	Additional Director	02 Aug 2019	Past
Pramod Abcsdd	Director	02 Aug 2019	Past
Pramod Abcsdd	Director	27 Apr 2007	Past
Pramod Abcsdd	Whole-Time Director	31 Aug 2016	Past
Pramod Abcsdd	Director	31 Mar 2018	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Glaxosmithkline Consumer Healthcare.

Glaxosmithkline Consumer Healthcare Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 12.52% increase. The company also saw a substantial improvement in profitability, with a 40.38% increase in profit. The company's net worth Soared by an impressive increase of 17.49%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

12.52%

*******

Revenue from Operations

*******

9.25%

*******

Total Assets

*******

12.11%

*******

Profit or Loss

*******

40.38%

*******

Net Worth

*******

17.49%

*******

EBITDA

*******

29.16%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Glaxosmithkline Consumer Healthcare?

In 2019, Glaxosmithkline Consumer Healthcare had a promoter holding of 72.46% and a public holding of 27.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹2,795,000,000.00

Charges Breakdown by Lending Institutions

Bank Of America : 200.00 Cr
Deutsche Bank : 53.00 Cr
Bank Of America Nt And Sa : 26.50 Cr

Latest Charge Details

Date	Lender	Amount	Status
22 Dec 2006	Deutsche Bank	₹53.00 Cr	Satisfied
26 Jul 1995	Bank Of America	₹200.00 Cr	Satisfied
23 Mar 1993	Bank Of America Nt And Sa	₹26.50 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Glaxosmithkline Consumer Healthcare?

Glaxosmithkline Consumer Healthcare has a workforce of 1297 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Glaxosmithkline Consumer Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glaxosmithkline Consumer Healthcare's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Glaxosmithkline Consumer Healthcare

Recent Activity within the Organization

Director Appointment

Nitin Mathur was appointed as a CFO was appointed as a CFO on 01 Nov 2019 & has been associated with this company since 6 years 4 months . was recorded as a recent event.
01 Nov 2019
Director Appointment

Nitin Mathur was appointed as a CFO was appointed as a CFO on 01 Nov 2019 & has been associated with this company since 6 years 4 months . was recorded as a recent event.
01 Nov 2019
Annual General Meeting

The activity Glaxosmithkline Consumer Healthcare Limited last Annual general meeting of members was held on 02 Aug 2019 as per latest MCA records. was completed.
02 Aug 2019
Director Appointment

Pradeep Vasudeo Bhide was appointed as a Director was appointed as a Director on 10 May 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.
10 May 2019
Balance Sheet

Progress on Glaxosmithkline Consumer Healthcare Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Chandigarh. was documented.
31 Mar 2019
Director Appointment

Progress on Subramanian Madhavan was appointed as a Director was appointed as a Director on 25 Sep 2018 & has been associated with this company since 7 years 5 months . was documented.
25 Sep 2018

Explore recent activity and updates - View Recent Activity